Laboratory tests for live attenuated poliovirus vaccines

Area of Science:

• Virology
• Vaccinology
• Molecular Biology

Background:

• Live attenuated poliovirus vaccines (LVP) require stringent quality control.
• Advances in understanding poliovirus molecular biology inform new vaccine control strategies.
• Existing control tests have limitations in standardization and informativeness.

Purpose of the Study:

• To review and evaluate novel and existing methods for controlling live attenuated poliovirus vaccines.
• To assess the suitability of new molecular-based tests for regulatory use.
• To critically analyze the relevance and standardization of current vaccine control assays.

Main Methods:

• Development of an in vivo neurovirulence test in transgenic mice.
• Implementation of an in vitro MAPREC (mutant analysis by polymerase chain reaction and restriction enzyme cleavage assay) test.
• Critical review of existing World Health Organization (WHO) neurovirulence and rct40 tests.

Main Results:

• New in vivo and in vitro tests show excellent progress but are not yet ready for regulatory implementation.
• The WHO neurovirulence test is well-standardized and valuable for batch assessment.
• The current rct40 test lacks standardization and informativeness; improvements are possible.
• The relevance of d or antigenic marker tests is questionable.

Conclusions:

• Novel molecular-based tests offer potential for improved poliovirus vaccine control.
• Further development is needed to validate new methods for regulatory applications.
• Established tests like WHO neurovirulence remain critical, while others require reassessment or enhancement.
• Potency, identity, and thermal stability tests are essential for final trivalent vaccine quality assurance.